AgeneBio
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of AGB101 for Mild Cognitive Impairment (NCT05986721) | AgeneBio | 2024-12-03 |
| Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease (NCT03486938) | AgeneBio | 2018-12-13 |
Track AgeneBio automatically
Every clearance here is in the API, with alerts when new ones post.